Unit:
Bureau of Industry and Information Technology, Haicang District; Xiamen Haicang Biotechnology Development Co., Ltd.; Bureau of Industry and Information Technology, Xiang’an District
Project Area:
xiamen Xiamen Biomedical Port; Xiang’an Digital Economy Industrial Park
Industry:
Biological and New Pharmaceutical Industry
Type of Project:
New Project
Cooperation Mode:
Collaborate
Nature of Project:
Encourage
Working Progress in Prior Period:
none
Total Investment:
discussed in detai
Expected to Attract Investment:
discussed in detai
Benefit Analysis:
none
Reason and Condition:
none
Content and Scale:
1. Xiamen Biomedical Port: It intends to introduce enterprises of new type vaccines, recombinant protein drugs, biomacromolecule drugs, innovative small molecule drugs, siRNA drugs, targeted drugs, and modified new drugs. It also introduces platforms for the design, screening, and validation of innovative chemical drugs, platforms for new types of drug carriers and sustained-controlled-release technologies and modern high-end biomedical projects.2. Xiang’an Digital Economy Industrial Park: It plans to introduce in vitro diagnostic reagents and core raw materials such as immunodiagnostics, molecular diagnosis, POCT, and a new generation of fully automated diagnostic equipment. All kinds of artificial organs, cardiovascular, nerve, and other high-end implantable interventional products, high-end medical imaging equipment, tumor treatment equipment, respiratory equipment, and consumables. It will also develop health management equipment and high-performance medical devices such as chronic disease monitoring and management, wearable remote diagnosis and treatment, and remote health management.
Others:
none
Industry

Biological & New Pharmaceutical Industry

In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.